Inhaler

DEVICE3 trials

Sponsors

Istanbul University - Cerrahpasa, Boehringer Ingelheim, AstraZeneca

Conditions

AromatherapyAsthmaCesarean Section ComplicationsCystic FibrosisPostpartum PeriodPrimiparity

Phase 1

A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1)

TerminatedNCT06515002

Boehringer IngelheimCystic Fibrosis

Start: 2024-11-04End: 2025-10-30Updated: 2026-02-19

Phase 2

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

CompletedNCT06529419

AstraZenecaAsthma

Start: 2024-08-30End: 2026-02-04Updated: 2026-03-02

Unknown Phase

The Effect of Aromatherapy in Women With Primiparous Cesarean Section

CompletedNCT06119282

Istanbul University - CerrahpasaAromatherapy, Cesarean Section Complications, Postpartum Period +1

Start: 2022-06-01End: 2024-09-01Updated: 2024-09-19